PR1 Vaccination in Myelodysplastic Syndrome (MDS)

NCT00893997 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

12

Enrollment

OTHER

Sponsor class

Stopped The trial was ended per sponsor due to slow accrual rates.

Conditions

Leukemia
Myelodysplastic Syndrome

Interventions

BIOLOGICAL: PR-1 vaccine

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]